Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data.

Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K.

Diabetes Ther. 2019 Apr 26. doi: 10.1007/s13300-019-0615-5. [Epub ahead of print]

PMID:
31028689
2.

Patient preferences and health state utilities associated with dulaglutide and semaglutide injection devices among patients with type 2 diabetes in Italy.

Boye KS, Matza LS, Stewart KD, Jordan J, Biricolti G, Del Santo S, Perez-Nieves M, Federici MO, Gentilella R, Losi S, Norrbacka K.

J Med Econ. 2019 Apr 23:1-8. doi: 10.1080/13696998.2019.1609482. [Epub ahead of print]

PMID:
31010349
3.

The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetes.

Lage MJ, Boye KS, Bae JP, Wu J, Mody R, Botros FT.

J Med Econ. 2019 May;22(5):447-454. doi: 10.1080/13696998.2019.1581208. Epub 2019 Mar 4.

PMID:
30736708
4.

Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States.

Boye KS, Riddle MC, Gerstein HC, Mody R, Garcia-Perez LE, Karanikas CA, Lage MJ, Riesmeyer JS, Lakshmanan MC.

Diabetes Obes Metab. 2019 Jun;21(6):1299-1304. doi: 10.1111/dom.13649. Epub 2019 Mar 12.

PMID:
30714309
5.

Uranium storage mechanisms in wet-dry redox cycled sediments.

Noël V, Boye K, Kukkadapu RK, Li Q, Bargar JR.

Water Res. 2019 Apr 1;152:251-263. doi: 10.1016/j.watres.2018.12.040. Epub 2019 Jan 12.

PMID:
30682569
6.

Prepositions and pronouns in connected discourse of individuals with aphasia.

Martínez-Ferreiro S, Ishkhanyan B, Rosell-Clarí V, Boye K.

Clin Linguist Phon. 2019;33(6):497-517. doi: 10.1080/02699206.2018.1551935. Epub 2018 Dec 11.

PMID:
30526143
7.

Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour.

Hølmebakk T, Bjerkehagen B, Hompland I, Stoldt S, Boye K.

Br J Surg. 2019 Mar;106(4):419-426. doi: 10.1002/bjs.11027. Epub 2018 Dec 3.

PMID:
30507040
8.

Psychometric evaluation of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ).

Matza LS, Stewart KD, Paczkowski R, Coyne KS, Currie B, Boye KS.

J Patient Rep Outcomes. 2018 Sep 19;2:44. doi: 10.1186/s41687-018-0064-3. eCollection 2018 Dec.

9.

Development of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ).

Matza LS, Boye KS, Stewart KD, Paczkowski R, Jordan J, Murray LT.

J Patient Rep Outcomes. 2018 Sep 12;2:43. doi: 10.1186/s41687-018-0068-z. eCollection 2018 Dec.

10.

Multimodal kreftbehandling av gastrointestinal stromal tumor.

Hompland I, Hølmebakk T, Boye K, Stoldt S, Bjerkehagen B, Berner JM, Wiedswang AM, Revheim ME, Poulsen JP, Hall KS, Bruland ØS.

Tidsskr Nor Laegeforen. 2018 Oct 1;138(15). doi: 10.4045/tidsskr.18.0200. Print 2018 Oct 2. Review. Norwegian.

11.

Soil exchange rates of COS and CO18O differ with the diversity of microbial communities and their carbonic anhydrase enzymes.

Meredith LK, Ogée J, Boye K, Singer E, Wingate L, von Sperber C, Sengupta A, Whelan M, Pang E, Keiluweit M, Brüggemann N, Berry JA, Welander PV.

ISME J. 2019 Feb;13(2):290-300. doi: 10.1038/s41396-018-0270-2. Epub 2018 Sep 13.

12.

Pazopanib in relapsed osteosarcoma patients: report on 15 cases.

Longhi A, Paioli A, Palmerini E, Cesari M, Abate ME, Setola E, Spinnato P, Donati D, Hompland I, Boye K.

Acta Oncol. 2019 Jan;58(1):124-128. doi: 10.1080/0284186X.2018.1503714. Epub 2018 Sep 12. No abstract available.

PMID:
30207179
13.

Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor.

Namløs HM, Boye K, Mishkin SJ, Barøy T, Lorenz S, Bjerkehagen B, Stratford EW, Munthe E, Kudlow BA, Myklebost O, Meza-Zepeda LA.

Mol Cancer Ther. 2018 Nov;17(11):2473-2480. doi: 10.1158/1535-7163.MCT-18-0174. Epub 2018 Aug 10.

PMID:
30097488
14.

Lacteal junction zippering protects against diet-induced obesity.

Zhang F, Zarkada G, Han J, Li J, Dubrac A, Ola R, Genet G, Boyé K, Michon P, Künzel SE, Camporez JP, Singh AK, Fong GH, Simons M, Tso P, Fernández-Hernando C, Shulman GI, Sessa WC, Eichmann A.

Science. 2018 Aug 10;361(6402):599-603. doi: 10.1126/science.aap9331.

15.

Effects of Dulaglutide and Insulin Glargine on Estimated Glomerular Filtration Rate in a Real-world Setting.

Boye KS, Mody R, Wu J, Lage MJ, Botros FT, Woodward B.

Clin Ther. 2018 Aug;40(8):1396-1407. doi: 10.1016/j.clinthera.2018.07.002. Epub 2018 Aug 6.

16.

Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes.

Matza LS, Boye KS, Jordan JB, Norrbacka K, Gentilella R, Tiebout AR, Browne C, Orsini Federici M, Biricolti G, Stewart KD.

Patient Prefer Adherence. 2018 Jun 6;12:971-979. doi: 10.2147/PPA.S159620. eCollection 2018.

17.

The Meeting Point: Where Language Production and Working Memory Share Resources.

Ishkhanyan B, Boye K, Mogensen J.

J Psycholinguist Res. 2019 Feb;48(1):61-79. doi: 10.1007/s10936-018-9589-0.

PMID:
29882117
18.

Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series.

Frezza AM, Jones RL, Lo Vullo S, Asano N, Lucibello F, Ben-Ami E, Ratan R, Teterycz P, Boye K, Brahmi M, Palmerini E, Fedenko A, Vincenzi B, Brunello A, Desar IME, Benjamin RS, Blay JY, Broto JM, Casali PG, Gelderblom H, Grignani G, Gronchi A, Hall KS, Mir O, Rutkowski P, Wagner AJ, Anurova O, Collini P, Dei Tos AP, Flucke U, Hornick JL, Lobmaier I, Philippe T, Picci P, Ranchere D, Renne SL, Sbaraglia M, Thway K, Wagrodzki M, Wang WL, Yoshida A, Mariani L, Kawai A, Stacchiotti S.

JAMA Oncol. 2018 Sep 1;4(9):e180219. doi: 10.1001/jamaoncol.2018.0219. Epub 2018 Sep 13.

19.

Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement.

Mariathasan AB, Boye K, Giercksky KE, Brennhovd B, Gullestad HP, Emblemsvåg HL, Grøholt KK, Dueland S, Flatmark K, Larsen SG.

Eur J Surg Oncol. 2018 Aug;44(8):1226-1232. doi: 10.1016/j.ejso.2018.03.029. Epub 2018 Apr 12.

PMID:
29691115
20.

Patient perceptions of injection devices used with dulaglutide and liraglutide for treatment of type 2 diabetes.

Matza LS, Boye KS, Currie BM, Paczkowski R, Lando LF, Mody R, Jordan J.

Curr Med Res Opin. 2018 Aug;34(8):1457-1464. doi: 10.1080/03007995.2018.1465903. Epub 2018 May 14.

PMID:
29661026
21.

Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes.

Perez-Nieves M, Boye KS, Kiljanski J, Cao D, Lage MJ.

Diabetes Ther. 2018 Jun;9(3):1099-1111. doi: 10.1007/s13300-018-0421-5. Epub 2018 Apr 11.

22.

Treating Type 1 Diabetes Mellitus with a Rapid-Acting Analog Insulin Regimen vs. Regular Human Insulin in Germany: A Long-Term Cost-Effectiveness Evaluation.

Valentine WJ, Van Brunt K, Boye KS, Pollock RF.

Appl Health Econ Health Policy. 2018 Jun;16(3):357-366. doi: 10.1007/s40258-018-0379-5.

PMID:
29525908
23.

Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population.

Boye KS, Botros FT, Haupt A, Woodward B, Lage MJ.

Diabetes Ther. 2018 Apr;9(2):637-650. doi: 10.1007/s13300-018-0377-5. Epub 2018 Feb 19.

24.

Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study.

Hølmebakk T, Hompland I, Bjerkehagen B, Stoldt S, Bruland ØS, Hall KS, Boye K.

Ann Surg Oncol. 2018 May;25(5):1133-1139. doi: 10.1245/s10434-018-6353-5. Epub 2018 Feb 12.

PMID:
29435684
25.

Genotype and risk of tumour rupture in gastrointestinal stromal tumour.

Boye K, Berner JM, Hompland I, Bruland ØS, Stoldt S, Sundby Hall K, Bjerkehagen B, Hølmebakk T.

Br J Surg. 2018 Jan;105(2):e169-e175. doi: 10.1002/bjs.10743.

PMID:
29341147
26.

Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes.

Matza LS, Boye KS, Stewart KD, Davies EW, Paczkowski R.

BMC Health Serv Res. 2017 Nov 25;17(1):774. doi: 10.1186/s12913-017-2648-7.

27.

The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors.

Boyé K, Pujol N, D Alves I, Chen YP, Daubon T, Lee YZ, Dedieu S, Constantin M, Bello L, Rossi M, Bjerkvig R, Sue SC, Bikfalvi A, Billottet C.

Nat Commun. 2017 Nov 17;8(1):1571. doi: 10.1038/s41467-017-01686-y.

28.

Contrasting Grammatical and Lexical Determiners.

Lange VM, Messerschmidt M, Boye K.

J Psycholinguist Res. 2018 Jun;47(3):467-482. doi: 10.1007/s10936-017-9531-x.

PMID:
29116479
29.

Patient-reported Outcomes in Patients with Type 2 Diabetes Treated with Dulaglutide Added to Titrated Insulin Glargine (AWARD-9).

Yu M, Brunt KV, Milicevic Z, Varnado O, Boye KS.

Clin Ther. 2017 Nov;39(11):2284-2295. doi: 10.1016/j.clinthera.2017.10.002. Epub 2017 Oct 27.

PMID:
29110972
30.

Planning and production of grammatical and lexical verbs in multi-word messages.

Michel Lange V, Messerschmidt M, Harder P, Siebner HR, Boye K.

PLoS One. 2017 Nov 1;12(11):e0186685. doi: 10.1371/journal.pone.0186685. eCollection 2017.

31.

Oligomerization State of CXCL4 Chemokines Regulates G Protein-Coupled Receptor Activation.

Chen YP, Wu HL, Boyé K, Pan CY, Chen YC, Pujol N, Lin CW, Chiu LY, Billottet C, Alves ID, Bikfalvi A, Sue SC.

ACS Chem Biol. 2017 Nov 17;12(11):2767-2778. doi: 10.1021/acschembio.7b00704. Epub 2017 Oct 4.

PMID:
28945356
32.

Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR).

Boyé K, Billottet C, Pujol N, Alves ID, Bikfalvi A.

Sci Rep. 2017 Sep 6;7(1):10703. doi: 10.1038/s41598-017-11151-x.

33.

Redox Controls over the Stability of U(IV) in Floodplains of the Upper Colorado River Basin.

Noël V, Boye K, Lezama Pacheco JS, Bone SE, Janot N, Cardarelli E, Williams KH, Bargar JR.

Environ Sci Technol. 2017 Oct 3;51(19):10954-10964. doi: 10.1021/acs.est.7b02203. Epub 2017 Sep 21.

34.

Medication adherence and improved outcomes among patients with type 2 diabetes.

Curtis SE, Boye KS, Lage MJ, Garcia-Perez LE.

Am J Manag Care. 2017 Jul 1;23(7):e208-e214.

35.

CREED study: Hypoglycaemia during Ramadan in individuals with Type 2 diabetes mellitus from three continents.

Jabbar A, Hassanein M, Beshyah SA, Boye KS, Yu M, Babineaux SM.

Diabetes Res Clin Pract. 2017 Oct;132:19-26. doi: 10.1016/j.diabres.2017.07.014. Epub 2017 Jul 13.

36.

Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate.

Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA, Hagene KT, Aas E, Lurås H, Johnsen-Soriano S, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Mælandsmo GM, Flatmark K.

ESMO Open. 2017 May 2;2(2):e000158. doi: 10.1136/esmoopen-2017-000158. eCollection 2017.

37.

Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.

Stacchiotti S, Mir O, Le Cesne A, Vincenzi B, Fedenko A, Maki RG, Somaiah N, Patel S, Brahmi M, Blay JY, Boye K, Sundby Hall K, Gelderblom H, Hindi N, Martin-Broto J, Kosela H, Rutkowski P, Italiano A, Duffaud F, Kobayashi E, Casali PG, Provenzano S, Kawai A.

Oncologist. 2018 Jan;23(1):62-70. doi: 10.1634/theoncologist.2017-0161. Epub 2017 Jul 28.

38.

Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review.

Kennedy-Martin T, Boye KS, Peng X.

Patient Prefer Adherence. 2017 Jun 30;11:1103-1117. doi: 10.2147/PPA.S136639. eCollection 2017. Review.

39.

The Prime Diabetes Model: Novel Methods for Estimating Long-Term Clinical and Cost Outcomes in Type 1 Diabetes Mellitus.

Valentine WJ, Pollock RF, Saunders R, Bae J, Norrbacka K, Boye K.

Value Health. 2017 Jul - Aug;20(7):985-991. doi: 10.1016/j.jval.2016.12.001. Epub 2017 May 4.

41.

Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort.

Hompland I, Bruland ØS, Hølmebakk T, Poulsen JP, Stoldt S, Hall KS, Boye K.

Acta Oncol. 2017 Oct;56(10):1317-1323. doi: 10.1080/0284186X.2017.1330555. Epub 2017 May 30.

PMID:
28557540
42.

Stagnation only on the surface? The implications of skill and family responsibilities for the gender wage gap in Sweden, 1974-2010.

Boye K, Halldén K, Magnusson C.

Br J Sociol. 2017 Dec;68(4):595-619. doi: 10.1111/1468-4446.12252. Epub 2017 Mar 31.

PMID:
28369726
43.

Understanding controls on redox processes in floodplain sediments of the Upper Colorado River Basin.

Noël V, Boye K, Kukkadapu RK, Bone S, Lezama Pacheco JS, Cardarelli E, Janot N, Fendorf S, Williams KH, Bargar JR.

Sci Total Environ. 2017 Dec 15;603-604:663-675. doi: 10.1016/j.scitotenv.2017.01.109. Epub 2017 Mar 27.

PMID:
28359569
44.

Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1.

Francolini G, Thomsen MS, Yates ES, Kirkove C, Jensen I, Blix ES, Kamby C, Nielsen MH, Krause M, Berg M, Mjaaland I, Schreiber A, Kasti UM, Boye K, Offersen BV.

Radiother Oncol. 2017 May;123(2):282-287. doi: 10.1016/j.radonc.2017.03.011. Epub 2017 Mar 25.

PMID:
28351523
45.

Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort.

Boye K, Jebsen NL, Zaikova O, Knobel H, Løndalen AM, Trovik CS, Monge OR, Hall KS.

Acta Oncol. 2017 Mar;56(3):479-483. doi: 10.1080/0284186X.2016.1278305. Epub 2017 Jan 20.

PMID:
28105885
46.

GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries.

Divino V, DeKoven M, Khan FA, Boye KS, Sapin H, Norrbacka K.

Diabetes Ther. 2017 Feb;8(1):115-128. doi: 10.1007/s13300-016-0224-5. Epub 2017 Jan 9.

47.

Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report.

Namløs HM, Zaikova O, Bjerkehagen B, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA.

BMC Cancer. 2017 Jan 6;17(1):29. doi: 10.1186/s12885-016-2992-8.

48.

Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.

Egeland EV, Boye K, Park D, Synnestvedt M, Sauer T; Oslo Breast Cancer Consortium (OSBREAC), Naume B, Borgen E, Mælandsmo GM.

Breast Cancer Res Treat. 2017 Feb;162(1):127-137. doi: 10.1007/s10549-016-4096-1. Epub 2017 Jan 5.

PMID:
28058579
49.

Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour.

Hompland I, Bruland ØS, Ubhayasekhera K, Bergquist J, Boye K.

Clin Sarcoma Res. 2016 Dec 15;6:21. doi: 10.1186/s13569-016-0062-2. eCollection 2016.

50.

Utilities for Type 2 Diabetes Treatment-Related Attributes in a South Korean and Taiwanese Population.

Rajan N, Boye KS, Gibbs M, Lee YJ, Davey P, Ball M, Babineaux SM.

Value Health Reg Issues. 2016 May;9:67-71. doi: 10.1016/j.vhri.2015.11.006. Epub 2016 Feb 3.

PMID:
27881263

Supplemental Content

Support Center